Toggle Navigation


Gynuity is collaborating with IPPF-ESEAOR and in-country colleagues to introduce mifepristone medical abortion technology for termination of pregnancy in the first trimester and to broaden capacity for the provision of safe high quality services. Initial stage activities include implementing clinical research on mifepristone-misoprostol medical abortion, conducting staff trainings, developing and preparing a team of local trainers to ensure capacity building among new staff and other clinics, and providing technical assistance on service delivery-related issues. It is our hope that these efforts contribute to the registration of a mifepristone product in Indonesia to facilitate continued access to safe medical abortion services.

Back to World Map